Lumboperitoneal shunting of cerebrospinal fluid versus anti-tumor necrosis factor treatment of cauda equina syndrome in ankylosing spondylitis: comment on the article by Cornec et al

Arthritis Rheum. 2010 May;62(5):1559-60; author reply 1560-1. doi: 10.1002/art.27413.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Cerebrospinal Fluid Shunts*
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Magnetic Resonance Imaging
  • Polyradiculopathy* / drug therapy
  • Polyradiculopathy* / pathology
  • Polyradiculopathy* / surgery
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Spondylitis, Ankylosing / pathology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept